Created at Source Raw Value Validated value
June 25, 2024, noon usa

* mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation * known or suspected allergy against pulmozyme * chronic obstructive pulmonary disease stage iii-iv or another comparable chronic respiratory disease * participation in a clinical study with an investigational product during the last 30 days * previous participation in this study * pregnancy. women of childbearing potential must agree to use contraceptives for the duration of the study period * any condition that, in the opinion of the investigator, would place the patient at increased risk or preclude the patient's compliance with the study

* mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation * known or suspected allergy against pulmozyme * chronic obstructive pulmonary disease stage iii-iv or another comparable chronic respiratory disease * participation in a clinical study with an investigational product during the last 30 days * previous participation in this study * pregnancy. women of childbearing potential must agree to use contraceptives for the duration of the study period * any condition that, in the opinion of the investigator, would place the patient at increased risk or preclude the patient's compliance with the study

Oct. 26, 2020, 11:31 p.m. usa

- mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation - known or suspected allergy against pulmozyme - chronic obstructive pulmonary disease stage iii-iv or another comparable chronic respiratory disease - participation in a clinical study with an investigational product during the last 30 days - previous participation in this study - pregnancy. women of childbearing potential must agree to use contraceptives for the duration of the study period - any condition that, in the opinion of the investigator, would place the patient at increased risk or preclude the patient's compliance with the study

- mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation - known or suspected allergy against pulmozyme - chronic obstructive pulmonary disease stage iii-iv or another comparable chronic respiratory disease - participation in a clinical study with an investigational product during the last 30 days - previous participation in this study - pregnancy. women of childbearing potential must agree to use contraceptives for the duration of the study period - any condition that, in the opinion of the investigator, would place the patient at increased risk or preclude the patient's compliance with the study